| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |